Raj Sewduth

10PUBLICATIONS
17CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 15, 2025
Intrinsic resistance to RAS inhibitors is driven by dysregulation of KRAS degradation.

Tonci Ivanisevic, Yan Ma, Emiel Van Boxel

|Jun 27, 2025
Molecular Design of Novel Protein-Degrading Therapeutics Agents Currently in Clinical Trial.

Ela Kacin, Raj Nayan Sewduth

|Jan 23, 2025
Cardiotoxicity of Chemotherapy: A Multi-OMIC Perspective.

Yan Ma, Mandy O J Grootaert, Raj N Sewduth

|Nov 27, 2024
Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation.

Katarina Vrbnjak, Raj Nayan Sewduth

|Sep 23, 2024
Multi-Omic Approaches in Cancer-Related Micropeptide Identification.

Katarina Vrbnjak, Raj Nayan Sewduth

|Jun 10, 2024
K128 ubiquitination constrains RAS activity by expanding its binding interface with GAP proteins.

Wout Magits, Mikhail Steklov, Hyunbum Jang

Pageof 2

Frequent Collaborators

2 joint publications

Wout Magits

2 joint publications

Anna Sablina

2 joint publications

Katarina Vrbnjak

2 joint publications

Maria Francesca Baietti